Brian Newman - 31 May 2025 Form 4 Insider Report for CVS HEALTH Corp (CVS)

Role: EVP, Chief Financial Officer
Signature: /s/ Brian Newman
Issuer symbol: CVS
Transactions as of: 31 May 2025
Net transactions value: +$1,399,978
Form type: 4
Filing time: 03 Jun 2025, 16:35:13 UTC
Previous filing: 14 May 2025
Next filing: 02 Jul 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Newman Brian	EVP, Chief Financial Officer	ONE CVS DRIVE, WOONSOCKET	/s/ Brian Newman	03 Jun 2025	0001788049

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CVS	Common Stock (RSUs)	Award	$1,399,978	+21,861		$64.04	21,861	31 May 2025	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CVS	Stock Option	Award	$0	+94,786		$0.000000	94,786	31 May 2025	Common Stock	94,786	$64.04	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Consists of restricted stock units awarded pursuant to Issuer's 2017 Incentive Compensation Plan. Restrictions lapse in four equal installments, commencing 5/31/2026.
F2	Option becomes exercisable in four equal annual installments, commencing 5/31/2026.